Literature DB >> 12124460

The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence.

Nathan Bartlett1,2, Julian A Symons2, David C Tscharke1,2, Geoffrey L Smith1,2.   

Abstract

The vaccinia virus (VV) N1L gene encodes a protein of 14 kDa that was identified previously in the concentrated supernatant of virus-infected cells. Here we show that the protein is present predominantly (>90%) within cells rather than in the culture supernatant and it exists as a non-glycosylated, non-covalent homodimer. The N1L protein present in the culture supernatant was uncleaved at the N terminus and was released from cells more slowly than the VV A41L gene product, a secreted glycoprotein that has a conventional signal peptide. Bioinformatic analyses predict that the N1L protein is largely alpha-helical and show that it is conserved in many VV strains, in other orthopoxviruses and in members of other chordopoxvirus genera. However, database searches found no non-poxvirus proteins with significant amino acid similarity to N1L. A deletion mutant lacking the N1L gene replicated normally in cell culture, but was attenuated in intranasal and intradermal murine models compared to wild-type and revertant controls. The conservation of the N1L protein and the attenuated phenotype of the deletion mutant indicate an important role in the virus life-cycle.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12124460     DOI: 10.1099/0022-1317-83-8-1965

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  66 in total

1.  N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection.

Authors:  Meike S Gratz; Yasemin Suezer; Melanie Kremer; Asisa Volz; Monir Majzoub; Kay-Martin Hanschmann; Ulrich Kalinke; Astrid Schwantes; Gerd Sutter
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  The vaccinia virus-encoded Bcl-2 homologues do not act as direct Bax inhibitors.

Authors:  Antonio Postigo; Michael Way
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

3.  Vaccinia virus virulence factor N1L is a novel promising target for antiviral therapeutic intervention.

Authors:  Anton V Cheltsov; Mika Aoyagi; Alexander Aleshin; Eric Chi-Wang Yu; Taylor Gilliland; Dayong Zhai; Andrey A Bobkov; John C Reed; Robert C Liddington; Ruben Abagyan
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

4.  Structural insight into BH3 domain binding of vaccinia virus antiapoptotic F1L.

Authors:  Stephanie Campbell; John Thibault; Ninad Mehta; Peter M Colman; Michele Barry; Marc Kvansakul
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

5.  Vaccinia virus infection of mature dendritic cells results in activation of virus-specific naïve CD8+ T cells: a potential mechanism for direct presentation.

Authors:  Nicole L Yates; Martha A Alexander-Miller
Journal:  Virology       Date:  2006-10-20       Impact factor: 3.616

6.  Insertion of vaccinia virus C7L host range gene into NYVAC-B genome potentiates immune responses against HIV-1 antigens.

Authors:  José Luis Nájera; Carmen Elena Gómez; Juan García-Arriaza; Carlos Oscar Sorzano; Mariano Esteban
Journal:  PLoS One       Date:  2010-06-30       Impact factor: 3.240

7.  Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation.

Authors:  Motti Gerlic; Benjamin Faustin; Antonio Postigo; Eric Chi-Wang Yu; Martina Proell; Naran Gombosuren; Maryla Krajewska; Rachel Flynn; Michael Croft; Michael Way; Arnold Satterthwait; Robert C Liddington; Shahram Salek-Ardakani; Shu-ichi Matsuzawa; John C Reed
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-19       Impact factor: 11.205

8.  Vaccinia virus lacking the Bcl-2-like protein N1 induces a stronger natural killer cell response to infection.

Authors:  Nathalie Jacobs; Nathan W Bartlett; Richard H Clark; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2008-11       Impact factor: 3.891

9.  Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence.

Authors:  Aodhnait S Fahy; Richard H Clark; Emily F Glyde; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2008-10       Impact factor: 3.891

10.  Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein.

Authors:  Samantha Cooray; Mohammad W Bahar; Nicola G A Abrescia; Colin E McVey; Nathan W Bartlett; Ron A-J Chen; David I Stuart; Jonathan M Grimes; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2007-06       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.